Anyang-i si, South Korea

Pan-Soo Kim




Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Anyang-si, KR (2010)
  • Anyang-i si, KR (2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Inventor Pan-Soo Kim: Advancements in Osteoporosis Treatment**

Introduction

Pan-Soo Kim, a notable inventor based in Anyang-i si, South Korea, has made significant contributions to the field of pharmaceutical science through his innovative research. With a total of three patents to his name, Kim focuses primarily on the development of compounds aimed at treating osteoporosis, a condition affecting millions worldwide.

Latest Patents

Pan-Soo Kim's most recent patents involve the use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for the prophylaxis and treatment of osteoporosis. His inventions encompass a pharmaceutical composition that includes 4-[(4-thiazolyl)phenoxyl]alkoxy-benzamidine derivatives. The detailed formula outlines specific compounds like 4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine, which aim to combat osteoporosis effectively. This innovation not only provides a method for treating osteoporosis but also describes a way to inhibit osteoclast activity while stimulating osteoblast activity in subjects.

Career Highlights

As part of Dong Wha Pharmaceutical Co. Ltd., Pan-Soo Kim has established a commendable career focused on pharmaceutical innovation. His work is pivotal in pursuing new treatments for serious health issues, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Kim has collaborated with esteemed colleagues, including Hong-Suk Suh and Yun-Ha Hwang. Together, they contribute to a dynamic research environment that fosters innovation and creativity in the development of new pharmaceutical solutions.

Conclusion

Pan-Soo Kim stands out as a dedicated inventor whose research is instrumental in addressing osteoporosis treatment. His innovative approach and collaborative efforts at Dong Wha Pharmaceutical Co. Ltd. not only enhance the pharmaceutical industry's knowledge but also offer hope and improved quality of life for those affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…